Related Experiment Video
Updated: Jun 4, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and
Hoonhee Seo1, Sukyung Kim1, Samuel Beck2
1Human Microbiome Medical Research Center (HM·MRC), School of Medicine, Soonchunhyang University, 22, Soonchunhyang-ro, Sinchang-myeon, Asan-si 31538, Chungnam-do, Republic of Korea.
Abstract:
Although global life expectancy has increased over the past 20 years due to advancements in managing infectious diseases, one-fifth of people still die from infections. In response to this ongoing threat, significant efforts are underway to develop vaccines and antimicrobial agents. However, pathogens evolve resistance mechanisms, complicating their control. The COVID-19 pandemic has underscored the limitations of focusing solely on the pathogen-killing strategies of immunology and microbiology to address complex, multisystemic infectious diseases. This highlights the urgent need for practical advancements, such as microbiome therapeutics, that address these limitations while complementing traditional approaches. Our review emphasizes key outcomes in the field, including evidence of probiotics reducing disease severity and insights into host-microbiome crosstalk that have informed novel therapeutic strategies. These findings underscore the potential of microbiome-based interventions to promote physiological function alongside existing strategies aimed at enhancing host immune responses and pathogen destruction. This narrative review explores microbiome therapeutics as next-generation treatments for infectious diseases, focusing on the application of probiotics and their role in host-microbiome interactions. While offering a novel perspective grounded in a cooperative defense system, this review also addresses the practical challenges and limitations in translating these advancements into clinical settings.
Insights
Microbiome therapeutics, like probiotics, offer a new way to fight infectious diseases by working with the body. These approaches complement traditional methods and show promise for reducing disease severity.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Global life expectancy has risen, yet infectious diseases remain a major cause of death.
- Antimicrobial resistance and evolving pathogens necessitate novel therapeutic strategies.
- The COVID-19 pandemic highlighted the need for approaches beyond pathogen-killing.
Purpose of the Study:
- To explore microbiome therapeutics as next-generation treatments for infectious diseases.
- To review the role of probiotics and host-microbiome interactions in managing infections.
- To discuss the potential and challenges of translating microbiome-based interventions into clinical practice.
Main Methods:
- This narrative review synthesizes existing research on microbiome therapeutics.
- It focuses on probiotics and their mechanisms in host-microbiome crosstalk.
- Evidence for probiotics reducing disease severity and informing therapeutic strategies is examined.
Main Results:
- Probiotics have demonstrated potential in reducing infectious disease severity.
- Understanding host-microbiome crosstalk provides insights for novel therapeutic development.
- Microbiome interventions can promote physiological function alongside immune responses.
Conclusions:
- Microbiome therapeutics, particularly probiotics, represent a promising complementary strategy for infectious diseases.
- Harnessing host-microbiome interactions offers a novel approach to infectious disease management.
- Clinical translation of microbiome therapeutics faces practical challenges that require further investigation.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Biological Methods for Microbial Control
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Key Techniques in Microbiology
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

